Detalhe da pesquisa
1.
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369224
2.
Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial.
Gastroenterology
; 165(1): 149-161.e7, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004887
3.
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease.
J Pediatr Gastroenterol Nutr
; 78(4): 871-877, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356293
4.
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease.
Am J Gastroenterol
; 118(1): 129-137, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114773
5.
Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 20(8): 1881-1883.e1, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150924
6.
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls.
Am J Gastroenterol
; 117(1): 176-179, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797219
7.
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases.
Am J Gastroenterol
; 117(3): 462-469, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029167
8.
SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk.
J Perinatol
; 44(1): 28-34, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092879
9.
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.
Clin Transl Gastroenterol
; 15(4): e00688, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349178
10.
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance.
Aliment Pharmacol Ther
; 57(5): 524-539, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36314265
11.
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
Inflamm Bowel Dis
; 29(8): 1202-1209, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103273
12.
Biotin Interference in Diagnostic Tests.
Clin Chem
; 63(2): 619-620, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28130485
13.
Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis.
Diagnostics (Basel)
; 12(7)2022 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35885566
14.
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease.
Aliment Pharmacol Ther
; 55(5): 593-603, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935161
15.
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection.
Microbiol Spectr
; 10(4): e0124722, 2022 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856710
16.
Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report.
Vaccines (Basel)
; 11(1)2022 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679852
17.
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report.
medRxiv
; 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32995830
18.
State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry.
Clin Chem
; 54(8): 1290-7, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18556330
19.
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 29(10): 1662-1666, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788133
20.
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 29(3): 483-486, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830416